Pre-clinica evaluation of a novel HIV-1 vaccine statrgy [ 2015 - 2017 ]

Research Grant

Researchers: A/Pr Charani Ranasinghe (Principal investigator) ,  Prof Stephen Kent

Brief description Recently, we have designed two mucosal HIV vaccine strategies that temporary block hormone-like molecules IL-4/IL-13 at the vaccination site inducing excellent antibody and killer T cell immunity with protective efficacy in small animals. This project aims to evaluate the safety and efficacy of these novel HIV mucosal vaccines prior to clinical evaluation.

Funding Amount $AUD 528,440.16

Funding Scheme Development Grants

Notes Development Grant